XML 27 R10.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Cash and Investments | 12 Months Ended
--- | ---
Dec. 31, 2021
Cash and Cash Equivalents [Abstract] |
Cash and Investments | CASH AND INVESTMENTS Securities classified as cash and investments as of December 31, 2021 and 2020 are summarized below (in thousands). Estimated fair value is based on quoted market prices for these investments.
| December 31, 2021
|  |  | Gross Unrealized |  |
| Amortized Cost |  | Gains |  | Losses |  | Fair Value
Cash and cash equivalents: |  |  |  |  |  |  |
Money market funds | $ | 71,175 |  |  | $ | — |  |  | $ | — |  |  | $ | 71,175 |
Cash | 1,253 |  |  | — |  |  | — |  |  | 1,253 |
Total cash and cash equivalents | 72,428 |  |  | — |  |  | — |  |  | 72,428 |
Short-term investments: |  |  |  |  |  |  |
Commercial paper | $ | 31,936 |  |  | $ | 1 |  |  | $ | (2) |  |  | $ | 31,935 |
Corporate bonds | 7,025 |  |  | — |  |  | (3) |  |  | 7,022 |
Asset-backed securities | 5,306 |  |  | — |  |  | (2) |  |  | 5,304 |
U.S. treasury notes | — |  |  | — |  |  | — |  |  | — |
Total short-term investments | 44,267 |  |  | 1 |  |  | (7) |  |  | 44,261 |
Total cash equivalents and investments | $ | 116,695 |  |  | $ | 1 |  |  | $ | (7) |  |  | $ | 116,689 |
| December 31, 2020
|  |  | Gross Unrealized |  |
| Amortized Cost |  | Gains |  | Losses |  | Fair Value
Cash and cash equivalents: |  |  |  |  |  |  |
Money market funds | $ | 88,151 |  |  | $ | — |  |  | $ | — |  |  | $ | 88,151 |
Commercial paper | 2,100 |  |  | — |  |  | — |  |  | 2,100 |
Cash | 781 |  |  | — |  |  | — |  |  | 781 |
Total cash and cash equivalents | 91,032 |  |  | — |  |  | — |  |  | 91,032 |
Short-term investments |  |  |  |  |  |  |
Commercial paper | $ | 60,631 |  |  | $ | 2 |  |  | $ | (4) |  |  | $ | 60,629 |
Corporate bonds | 24,547 |  |  | 3 |  |  | (6) |  |  | 24,544 |
U.S. government-sponsored agency bonds | 9,277 |  |  | 2 |  |  | — |  |  | 9,279 |
U.S. treasury notes | 1,000 |  |  | — |  |  | — |  |  | 1,000 |
Total short-term investments | 95,455 |  |  | 7 |  |  | (10) |  |  | 95,452 |
Long-term investments: |  |  |  |  |  |  |
Corporate bonds | $ | 2,115 |  |  | $ | — |  |  | $ | (1) |  |  | $ | 2,114 |
Total cash equivalents and investments | $ | 188,602 |  |  | $ | 7 |  |  | $ | (11) |  |  | $ | 188,598 |
Cash equivalents consist of money market funds and other debt securities with original maturities of three months or less at the time of purchase, and the carrying amount is a reasonable approximation of fair value. We invest our cash in high quality securities of financial and commercial institutions. These securities are carried at fair value, which is based on readily available market information, with unrealized gains and losses included in accumulated other comprehensive income (loss) within stockholders’ equity on ours balance sheets. We use the specific identification method to determine the amount of realized gains or losses on sales of marketable securities. Realized gains or losses have been insignificant and are included in other income (expense), net, in the statement of operations. All short-term available-for-sale securities held as of December 31, 2021 and 2020, had contractual maturities of less than one year. The long-term securities held as of December 31, 2020 had contractual maturities greater than one year. Our available-for-sale securities are subject to a periodic impairment review. We consider a debt security to be impaired when its fair value is less than its carrying cost, in which case we would further review the investment to determine whether it is other-than-temporarily impaired. When we evaluate an investment for other-than-temporary impairment, we review factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, intent to sell, and whether it is more likely than not we will be required to sell the investment before the recovery of its cost basis. If an investment is other-than-temporarily impaired, we write it down through the statement of operations to its fair value and establishes that value as a new cost basis for the investment. We did not identify any of its available-for-sale securities as other-than-temporarily impaired in any of the periods presented. As of December 31, 2021 and 2020, no investment was in a continuous unrealized loss position for more than one year and we believe that it is more likely than not that the investments will be held until maturity or a forecasted recovery of fair value. As of December 31, 2021, the amortized cost and estimated fair value of available-for-sale debt securities by contractual maturity were as follows (in thousands):
| Amortized Cost |  | Fair Value
Due in one year or less | $ | 44,267 |  |  | $ | 44,261 |

X
- References No definition available. + Details
Name: | us-gaap_CashAndCashEquivalentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of the components of cash, cash equivalents, and short-term investments. Short-term investments may include current marketable securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -URI http://asc.fasb.org/topic&trid=2196928 + Details
Name: | us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration